OTC:RAJAF | Income Statement | TFA Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2021-12-31 to 2025-12-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2023-12-31$315,502.00-$4,100.00$284,660.00$164,212.00$120,448.00$83,430.00$901,171.00$0.01$0.0100
2022-12-31$76,459.00-$36,901.00-$36,891.00-$77,046.00$0.00$0.004,417,5344,417,534

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.25M$484,607.00$760,741.00$901,869.00-$141,128.00-$13,694.00-$154,822.00-$154,822.00$0.00$0.00111,120,000111,120,000
2024-12-31$1.25M$347,004.00$906,480.00$1.09M-$183,913.00-$7,388.00-$191,301.00$34,957.00-$226,258.00$0.00$0.00111,120,000111,120,000
2023-12-31$882,533.00$116,146.00$766,387.00$538,554.00$227,833.00-$37,018.00$190,815.00$21,530.00$751,609.00$0.01$0.01111,120,000111,120,000
2022-12-31$53,304.00$13,746.00$39,558.00$118,444.00$454,679.00-$415,121.00$10.00-$415,111.00$792.00-$720,093.00-$0.01-$0.01104,417,534104,417,534
2021-12-31$879,318.00$1.06M-$176,212.00$25,052.00$119,387.00-$119,387.00$7.00-$119,380.00$351.00-$491,006.00$0.00$0.00100,000100,000

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.